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Abstract
For over a decade, the application of acoustic radiation force (ARF) has been proposed as a
mechanism to increase ultrasonic molecular imaging (MI) sensitivity in vivo. Presented herein is
the first noninvasive in vivo validation of ARF-enhanced MI with an unmodified clinical system.
First, an in vitro optical-acoustical setup was used to optimize system parameters and ensure
sufficient microbubble translation when exposed to ARF. 3D ARF-enhanced MI was then
performed on 7 rat fibrosarcoma tumors using microbubbles targeted to αvβ3 and non-targeted
microbubbles. Low-amplitude (< 25 kPa) 3D ARF pulse sequences were tested and compared to
passive targeting studies in the same animal. Our results demonstrate that a 78% increase in image
intensity from targeted microbubbles can be achieved when using ARF relative to the passive
targeting studies. Furthermore, ARF did not significantly increase image contrast when applied to
non-targeted agents, suggesting that ARF did not increase non-specific adhesion.
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Introduction
Since early observations of acoustic radiation force (ARF) on microbubble contrast agents,
researchers have speculated about the utility of this force to push populations of
microbubbles in a direction normal to their flow in a patient’s vasculature, thereby guiding
them out of circulation and against the wall of a vessel (Dayton et al. 1999). It has been
hypothesized that increasing ligand-receptor proximity and reducing the velocity of flowing
microbubbles would greatly increase the amount of targeted microbubble adhesion in
molecular imaging studies (Dayton et al. 2002; Rychak et al. 2007; Rychak et al. 2005; Zhao
et al. 2004; Borden et al. 2006). In vitro studies of ARF on microbubbles have demonstrated
the ability to increase the quantity of microbubble adhesion over 100 fold compared to
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molecular targeting without ARF (Rychak et al. 2005). In vivo observations performed by
intravital microscopy have also demonstrated between four and twenty-fold increases
(depending on the vascular environment) in the amount of targeted microbubbles retained in
microvasculature after ARF pulses (Rychak et al. 2007). Similarly, with the development of
acoustically-active drug delivery vehicles, it has been hypothesized that ARF could be a
mechanism to increase vehicle and drug concentration at the desired target site via
ultrasound. Researchers have shown the utility of ARF to mediate the concentration of
several types of potential therapeutic delivery vehicles (Shortencarier et al. 2004; Lum et al.
2006; Kheirolomoom et al. 2007).
It has also been proposed that ARF might play a role in pulse sequences designed to enhance
the detection of targeted contrast agents in molecular imaging. Many current molecular
imaging studies involve the use of a waiting period, typically 5–20 minutes, for free
(unbound) microbubbles to clear the circulation before imaging of adherent targeted agents
can be performed (Lindner et al. 2001). This limitation makes molecular imaging with
ultrasound a slow process and likely results in loss of detected signal, as bound
microbubbles can detach or degrade over the waiting period. It has been shown that rapid
increase in adhesion of targeted microbubbles using ARF can be utilized to help delineate
signal from free and bound contrast agents (Patil et al. 2009; Zhao et al. 2007).
However, to date, literature demonstrating the application of ARF in vivo to improve
microbubble targeting has been scarce. This is likely due to a disparity between the types of
acoustic pulses used for imaging by clinical and preclinical imaging systems, and the
acoustic regime over which ARF-induced microbubble displacement is most efficient.
Microbubble translation is maximized near the bubble’s resonant frequency. For most
efficient translation, a large duty cycle is required, and the mechanical index must be low
enough to avoid microbubble destruction (Dayton et al. 2002). A long duty cycle and low
mechanical index are typically not parameters beneficial for ultrasound imaging, and thus it
is likely that the paucity of in vivo ARF-enhanced molecular imaging data is due to the fact
that these pulse sequences are not intuitively available on commercial ultrasound equipment.
In this manuscript, we describe the implementation of a widely-used clinical ultrasound
system, the imaging parameters of which we have adjusted in order to produce ARF of a
magnitude substantial enough to cause non-destructive bubble translation. Following the
ARF pulses used to enhance contrast targeting, we utilize contrast-specific imaging pulse
sequences for molecular imaging. This study uses a fibrosarcoma tumor model to illustrate
the effect of ARF-enhanced molecular imaging compared to conventional passive molecular
imaging. Additionally, we investigate the effect on nonspecific adhesion caused by the
intentional push of microbubbles away from the center of the lumen toward the distal walls
within tumor vasculature. Results from preliminary in vitro studies are also presented which
suggest that the pressure of the ARF pulse sequence is a significant factor in promoting
lasting bond kinetics between molecularly targeted microbubbles and their target integrins,
and that one must balance detrimental over-pushing with ineffective under-pushing to
achieve the optimal ARF-enhanced molecular imaging protocol.
Materials and methods
A. Contrast Agents
All microbubbles used in our studies were formulated in-house as previously described
(Streeter et al. 2010). Briefly, targeted agents were fitted with a cyclic RGD peptide known
to bind to αvβ3, an integrin overexpressed on angiogenic endothelium. Likewise, non-
targeted microbubbles were produced with a similar lipid formulation, but without the
targeting ligand. Both targeted and non-targeted bubbles were of a diameter size distribution
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centered at 1.6 μm. This was achieved through a differential centrifugation technique
(Feshitan et al. 2009).
B. Imaging
Imaging was performed on a Siemens clinical ultrasound system (Acuson Sequoia 512,
Siemens Medical Solutions - Mountain View, CA) using a linear array transducer (model
15L8). The transducer was precisely positioned using a three-axis translational motion stage
setup, as previously described (Streeter et al. 2011), and the same probe was used for both
imaging and the application of ARF. For volumetric radiation force administration and
imaging, the transducer was swept in the elevational direction by a computer controlled
motion stage (Model UTS150PP - Newport, Irvine, CA) interfaced through LabView
(National Instruments, Austin, TX) to a desktop computer. This motion stage allowed 3D
images to be captured and ARF pulses to be delivered uniformly across the volume. ARF
pulses were optimized in the pulsed wave (PW) Doppler mode at a frequency of 7 MHz.
Adjusting the gate size (18 mm), location of the gate within the field (65 mm), and blood
velocity scale (1 m/sec) enabled us to achieve a 25% duty cycle pulse with a PRF of 25 kHz
(~70 cycles). The amplitude of the ARF pulses was modulated by using the power output
dial of the ultrasound system (range: −7 dB to 0 dB).
C. Calibration
Acoustic pressure measurements were determined by a calibrated needle hydrophone
(model: HNA-0400, Onda - Sunnyvale, CA) in a water tank. The acoustic pressures
produced by the linear array transducer in PW Doppler mode at the previously mentioned
parameters were measured at 100 μm increments in a 2.2 × 0.4 cm area in front of, and
parallel to, the aperture using the needle hydrophone. This region of the acoustic pressure
field was mapped at 0.5, 1, 1.5, and 2 cm distances from the aperture, for seven different
power output settings. The peak negative pressure was measured at each spatial location and
power output setting. These pressures were between 8 and 28 kPa for the system output
setting studied, and the pressure field deviated by less than 10% at the locations between 0.5
and 2 cm from the aperture face (in the water tank).
D. In vitro studies: effect of ARF pressure
In order to assess the relationship between output pressure and microbubble translation
efficiency, an optical-acoustical system was constructed to enable visualization of
microbubble translation during pulsing. A Photron high-speed camera (Model APX-RS –
San Diego, CA) was fitted with a 60x water immersion objective lens (LUMPlanFI/w,
Olympus - Melville, NY) through a single-tube microscope (Edmund Optics, Barrington,
NJ). The objective was inserted through a latex seal into the water tank and aligned
confocally with and at 90 degrees to the linear array transducer (Figure 1A). A 200 μm
acoustically and optically transparent cellulose tube (Spectrum Labs, Rancho Dominguez,
CA) was placed at the mutual focus, and a fiber optic illuminator was used as a light source
for the camera. A dilute concentration of contrast agents (2 × 107 bubbles/mL;
approximately 1:1000 from the initial concentration) was pumped through the tube and ARF
pulses were applied perpendicularly to both the flow direction and microbubble buoyancy.
Videos were acquired of the contrast agents as they were pushed by the ARF pulses across
the diameter of the tube. Data were analyzed offline and the spatial locations of the contrast
agents were mapped throughout their translation using a custom-designed program in
Matlab (Mathworks - Natick, MA). Bubble motion was tracked at each of the pressure
outputs, yielding a relationship between ARF-induced translational bubble velocity and
acoustic pressure amplitude.
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A second study was performed in which the axial dimension of the transducer was aligned
with the optical axis, and ARF pulses were used to push contrast agents toward the wall of
the tube closest to the lens (Figure 1B). The purpose of this study was to visualize the
behavior of microbubbles at the tube wall after initial ARF pulses had successfully pushed
them to the boundary, and thereby quantify conditions where “over-pushing“ occurred. We
define over-pushing as any ARF setting that caused microbubble destruction, or lateral
microbubble translation along the tube wall. At higher acoustic pressures, lateral motion
caused by both secondary radiation forces and force vectors along the curved tube surface in
response to primary radiation force would likely cause adherent microbubbles in vivo to be
knocked free. Thus, too much radiation force could be detrimental to molecular imaging
studies. Videos of the bubbles were acquired for several seconds as they were pushed into
the wall by ARF pulses, and analyzed later offline. Data were processed with a pixelwise
standard deviation projection through the time axis, thereby enabling the visualization of any
lateral movement of bubbles after they initially reached the tube wall.
E. In vitro studies: Estimating optimal in vivo study parameters
It is known that the amount of ARF experienced by a defined population of microbubbles is
a function of the acoustic pressure and the exposure time in the acoustic field. Prior to in
vivo studies, we estimated optimal experimental parameters for administering ARF to a
volume of tissue in which targeted contrast agents were circulating. We chose to utilize a
fixed translational speed of 1 mm·s−1 for the mechanically scanned transducer, as well as a
fixed duty cycle for all ARF administration. The optimal pressure, Po, was necessarily a
balance between efficient bubble translation and bubble-wall interactions. Our goal was to
design an experimental protocol in which ARF was applied uniformly across a volume of
tissue. Due to the effects of tissue attenuation, Po was not constant through the entire depth
of tissue. This necessitated a compromise between over-pushing in shallower regions of
tissue, and under-pushing at deeper regions of tissue. The optimal initial ARF pressure to
maximize targeting efficiency through a specific tumor size was estimated by taking the
minimum value of a cumulative error-function (CEF) defined as
(1)
where P(z) was the pressure of the radiation force beam derated for attenuation at depth z
into the tumor with an axial diameter D. Compensation for tissue attenuation is achieved via
the formula
(2)
where α is the attenuation coefficient for the tissue (Christensen 1988). A constant tissue
attenuation of 0.6 Np·cm−1 was assumed for the tumors used in the in vivo portion of the
study, as this falls within the range of attenuation values previously measured (D’Astous and
Foster 1986; Chang et al. 2007). The units of this CEF are in kPa, though the true values
returned by the equation are less important than the relative values between different power
output settings. We computed the CEF for each of the output settings on the ultrasound
system as a method for estimating the optimal ARF pressure amplitude for a given tumor
diameter. Similarly, we could estimate the axial distance travelled by microbubbles, Da,
within a volume of tissue as a result of the ARF pulses by computing
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where m is the slope of the curve for velocity of microbubbles as a function of pressure
(determined by the in vitro experiments with the schematic seen in Figure 1A, with units m·
(s·kPa)−1), P(z) is the pressure of the ARF beam at depth z, wb is the elevational width of the
ARF beam (3 mm), and vT is the elevational sweep velocity of the transducer during the
application of ARF. Thus, the first term in parenthesis will yield the average velocity of the
microbubbles exposed to ARF, and the second term will yield the amount of time they are
travelling. This calculation assumed an infinite potential path length (i.e. no tube wall to
prevent the bubble from being steadily translated).
F. In vivo experiments
Fischer 344 rats (Charles River Laboratories – Durham, NC) were used for studies of ARF-
enhanced and conventional molecular imaging (hereafter called “passive targeting“ studies,
i.e. those not implementing ARF). All animal studies were conducted in accordance with
protocols approved by the University of North Carolina School of Medicine’s Institutional
Animal Care and Use Committee.
Fibrosarcoma tumor models (N = 8) were established from propagated tumor tissue courtesy
of the Dewhirst Lab at Duke University. Prior to implantation, rats were anesthetized using
isoflurane and their left flank was shaved and disinfected. A 2 mm incision was made above
the quadriceps muscle and a ~ 1 mm3 piece of tumor tissue was placed subcutaneously.
Imaging was performed on tumors after their longest axis had grown to approximately 1 cm.
During the molecular imaging studies, animals were anesthetized with 2.5% inhaled
isoflurane anesthesia mixed with oxygen, and their body temperature was maintained at
37°C through the use of a temperature-controlled heating pad. The area to be imaged was
shaved, further depilated using a chemical hair remover, and then coupled to the ultrasound
transducer using gel as previously described (Streeter et al. 2011).
Microbubbles were administered in bolus injections via a 24-gauge tail vein catheter. The
concentrations of stock solutions for both the targeted and control bubbles were measured
prior to each imaging study using a particle sizer as previously described (Streeter et al.
2010). The appropriate volume of stock solution was added to the catheter via a micropipette
tip and flushed with 100 μL of sterile saline such that a contrast dose of 2 × 108 bubbles was
administered consistently. Because of the dose limitations with the injected volume of saline
and contrast into the animals, two different types of studies were performed over several
days to examine (a) the effect of ARF pulse amplitude on microbubble targeting efficiency
relative to passive targeting, and (b) the effect of ARF at promoting non-specific adhesion in
control bubbles relative to targeted bubbles also exposed to ARF.
For study type (a), each animal underwent four distinct injection and ARF protocols in the
following order: (1) passive targeting (no application of ARF) using targeted microbubbles
(2) application of ARF with a pressure of 4 kPa using targeted microbubbles (3) application
of ARF using a pressure of 13 kPa with targeted microbubbles (4) application of ARF with a
pressure of 21 kPa using targeted microbubbles. After each of these four imaging protocols,
there was a minimum wait time of 10 minutes to ensure that there were no circulating
microbubbles remaining. Similarly for study type (b), each animal underwent distinct
injection and ARF protocols in the following order: (1) passive targeting with control
microbubbles (2) application of ARF with a pressure of 13 kPa with control microbubbles
(3) passive targeting with targeted microbubbles (4) application of ARF with a pressure of
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13 kPa with targeted microbubbles. Between each type (b) experiment, there was a
minimum wait time of 10 minutes to ensure that there were no circulating microbubbles
remaining in the tumor vasculature. Due to injection volume limitations, study types (a) and
(b) were not performed in the same animal on the same day. In order to compare type (a)
and type (b) experiments, data were normalized to the mean image intensity within the
volumetric passive targeting image data (using targeted microbubbles without application of
ARF) in each animal because this imaging protocol occurred in both type (a) and type (b)
studies.
During all ARF-enhanced targeting studies, radiation force pulses were applied over the
entire volume of the tumor using the mechanically scanned transducer at pressures of 4, 13,
or 21 kPa (number of animals imaged at each setting: 4 kPa: N = 5, 13 kPa: N = 7, 21 kPa:
N = 5). The transducer was swept at a constant speed of 1 mm/s across the tumor volume
after contrast agents were administered to the animal, for a total of ten passes following the
injection. During passive targeting studies, ARF pulses were not administered (N = 4). After
waiting approximately 10 minutes for freely-circulating bubbles to clear from the animal’s
system, a 3D imaging scan was acquired across the tumor with inter-plane step sizes of 400
μm in the ultrasound system’s Cadence contrast imaging mode (CPS). The bound
microbubbles were then destroyed using a high mechanical index b-mode 3D scan, and then
the tumor reimaged in CPS mode at the same slice locations for a baseline measurement of
no targeted agents.
Our inter-image step-size was below the −6 dB elevational beam width determined in a
previous study (Feingold et al. 2010) to be ~ 800 μm. Thus the volumetric data was
downsampled offline at 800 μm intervals to yield independent imaging frames for analysis
as previously described (Streeter et al. 2010). The mean pixel intensities within the
background-subtracted images were computed, producing a mean targeted bubble intensity
for every 2D image plane within the 3D image acquisition. As previously mentioned, the
mean targeted microbubble intensity values were normalized to the mean of the passive
targeting microbubble injection. This allowed us to reduce the impact of inter-animal tumor
heterogeneity when making comparisons between animals. The brightness of adherent
MCAs was assumed to be correlated with the degree of biomarker expression. Thus,
throughout the remainder of this manuscript, “mean pixel intensity“ will refer to the quantity
defined by the difference between the average image’s intensity before the destruction pulse
and the average intensity of the image for the same region of interest after the destruction
pulse. This “mean pixel intensity“ metric is a way to approximate the quantity of adherent
microbubbles at a single 2D image slice’s location. The statistical significance of our
comparisons between the mean microbubble targeting measured by the different imaging
study settings was assessed by using Matlab to implement a two-sided Student’s t-test
assuming equal variances. Significance between two different distributions were considered
at a value of p < 0.05.
Results
A. In vitro studies: effect of ARF pressure
The positions of multiple bubbles (4 ≤ N ≤ 10) were tracked through space and time and a
linear relationship (R2 = 0.953) between velocity and radiation force amplitude was
observed, with a slope of 5.018 μm·(s·kPa)−1 (Figure 2A). For this linear curve fit, the y-
intercept was set to 0 (corresponding with a velocity of zero for microbubbles not exposed to
ARF).
At each acoustic pressure setting tested between 8 and 28 kPa, the ARF pulses were able to
force the microbubbles out of the center of the cellulose tube and against the wall. As the
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pressure was increased, the aggressiveness of the lateral bubble movement and aggregation
due to secondary radiation force increased (Figure 2B). Based on qualitative observations
from pixelwise time-axis standard deviation projections (Figure 2B), it was hypothesized
that the secondary radiation force at pressures greater than 10 kPa would not facilitate
lasting ligand-integrin bond kinetics, since ARF pressures above this threshold caused
bubbles to laterally translate along the cellulose tube wall. Thus, Po was estimated to be 10
kPa, as this setting would provide the best compromise between efficient bubble translation
(~50 μm/s) and minimization of lateral movement after contact with the vessel wall.
B. In vitro studies: Estimating optimal in vivo study parameters
The CEF computations demonstrated that there was no single pressure appropriate for all
tumor sizes. A 2D surface plot of the CEF values illustrates that for varying tumor sizes,
there exist different acoustic pressures that will optimize radiation-force enhanced targeting
over the entire tumor depth (Figure 3A). The CEF predicted that the 13 kPa pressure setting
would be the most effective in vivo protocol for a 1 cm tumor. A 4 kPa and a 21 kPa setting
were also tested in vivo to compare the relative targeting efficiencies to the 13 kPa setting
predicted by the CEF model.
The calculations of Da, the expected distance microbubbles would translate in vivo along the
ARF beam’s propagation axis, revealed that both the initial push pressure and the depth into
tissue determined whether a contrast agent would be sufficiently pushed out of circulation to
the luminal wall (Figure 3B). In a previous histological analysis of vessels within
xenografted tumors, 100 μm was the upper bound on the range of vessel diameters
(Palmowski et al. 2008). It was predicted that the three pressure settings tested in vivo would
provide sufficient microbubble translation (Da ≥ 50 μm) at tissue depths less than 3.1 cm,
2.4 cm, and 0.5 cm for the 21 kPa, 13 kPa and 4 kPa ARF amplitudes respectively.
C. In vivo results
Microbubbles targeted to angiogenic vasculature were used to compare ARF-enhanced
targeting to conventional passive targeting (Figure 4). Of the tested ARF pulsing schemes,
the maximum increase in microbubble targeting, as measured by mean pixel intensities, was
achieved using ARF pulses with a 13 kPa amplitude and a cRGD targeted bubble
(nomenclature: “RF-13/cRGD+“). In all of the animals that were tested, the volumetric
targeted intensity was greater using RF-13/cRGD+ than with passive targeting
(nomenclature: “RF-0/cRGD+”). Notably, there was improved microbubble retention in 91%
of all 2D image slices of RF-13/cRGD+ data collected when compared to the RF-0/cRGD+
studies (Table 1). In the remaining 9% of 2D image slices (in which the passive targeting
images were brighter than the RF-13/cRGD+ images), there was less than 1 dB difference
between the mean pixel intensity of RF-13/cRGD+ data as compared to the RF-0/cRGD+
case. Also of note, of the 9% of 2D image slices in which RF-13/cRGD+ was not as bright
as the passive targeting run, 80% of these were within the same animal. This was a likely an
indication of a less angiogenic and more necrotic tumor in this one animal, and thus there
was very little adhesion of targeted agents, either with or without ARF.
The increase in mean pixel intensity across all animals was 77.8% higher with the RF-13/
cRGD+ over the RF-0/cRGD+ case: 11.4 ± 7.0, compared to 6.4 ± 4.8 respectively. The
values represent baseline-subtracted pixel intensities, and thus the units are dB. The error in
these values is the standard deviation of the baseline-subtracted pixel intensities. Similarly,
both the RF-4 (8.8 ± 7.9) and RF-21 (8.8 ± 7.0) settings produced a statistically significant
increase in targeting of cRGD+ bubbles relative to the RF-0/cRGD+ case. Of note, the
RF-13/cRGD− case suggested a slight increase in mean pixel intensity for non-specific
microbubble adhesion relative to the RF-0/cRGD− case, however differences were not
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significant (p = 0.15). The histograms created from the amalgamation of all unnormalized
data show that, in general, the mean pixel intensity was higher for both ARF-enhanced and
passive targeting studies (Figure 4B) compared to non-targeted controls. Furthermore, these
histograms show that the RF-13/cRGD+ studies produced the greatest number of enhanced
pixels. Figure 5 illustrates an example of ARF-enhanced targeted imaging and conventional
passive targeting. In this image, the tumor volume is presented with a conically-stratified
hinged cutaway, wherein elliptical regions of interest were drawn such that they did not
follow the tumor border but instead cut into the interior of the tumor. This allows for
microbubble targeting from within the tumor margins to be visualized on the rendered 3D
surface, which we found was useful in visualizing 3D molecular imaging data.
Discussion
A. Optimizing radiation force: in vitro predictions and in vivo results
Using ARF to facilitate molecular targeting of microbubbles to integrins expressed on
diseased endothelium is an intuitive approach to improving the sensitivity of this diagnostic
imaging methodology, but its application is non-trivial. Our in vitro studies allowed us to
observe the behavior of microbubbles exposed to ARF pulses both during their translation
and after making contact with the wall of a vessel-mimicking phantom. These analyses
allowed us to tune parameters to predict the optimal settings for in vivo studies.
The calculation of the CEF demonstrated that because of the effects of tissue attenuation,
there is no single setting for ARF amplitude that is universally appropriate to increase
molecular imaging sensitivity at all tissue depths. Our CEF model predicted that ARF pulses
with 13 kPa pressure amplitude to be the most effective of the three amplitudes studied. The
model suggestions were supported by the in vivo study, as the 13 kPa pulses had the highest
microbubble targeting efficiency. The CEF predictions for the two other pressure amplitudes
tested (4 and 21 kPa) were very similar (Figure 3), which was also reflected in the in vivo
data, as these pressures resulted in similar increases in microbubble targeting, and were both
less effective than the 13 kPa ARF pulses. This CEF model assumed a constant attenuation
of 0.6 Np·cm−1 throughout the depth of the tumor, which did not take into account the
attenuation provided by the scatter of microbubbles in the tissue. Moreover, our method of
tuning ARF pressure via the CEF assumes that a uniform density of integrin (or other
biomarker) expression exists throughout the entire tumor volume. While this is likely not
true in the highly heterogeneous microenvironment of tumors, unless the heterogeneity is
known a priori, the best strategy for improving molecular targeting is one which maximizes
the probability of microbubble bond formation at all locations within the tumor.
Our in vivo studies demonstrated an average increase in microbubble targeting of nearly
80% relative to traditional passive targeting studies, as measured by average pixel intensities
within the baseline-subtracted images. It is important to emphasize that 91% of all the 2D
image slices within the ARF-enhanced datasets exhibited greater microbubble targeting than
the corresponding image frames taken from the passive targeting data. Of the remaining
slices that exhibited greater microbubble adhesion in the passive targeting case, most were
outliers found in a single animal that showed poor microbubble targeting in all experiments.
This, along with the rest of the data summarized in Table 1, makes a compelling argument
that ARF can improve the diagnostic utility of ultrasonic molecular imaging studies.
When comparing the control microbubbles (non-targeted) to the cyclic RGD microbubbles
(targeted) in the absence of ARF, it was apparent that non-specific targeting was observed
for the microbubble concentrations and tumor models used in this study. However, the
application of ARF significantly increased the mean pixel intensity from the targeted agents,
without significantly increasing the mean pixel intensity from the control agents – thereby
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providing a means to increase signal to noise in situations where there is a high non-specific
targeting background.
A persistent question surrounding the usefulness and applicability of ARF to in vivo
molecular imaging studies is whether pushing populations of bubbles away from the
proximal walls of vessels could actually be detrimental to maximizing the number of
microbubble-integrin bonds. While microbubble targeting on proximal vessel walls is likely
negligible during the application of ARF pulses, after the pulses stop, these binding sites are
free to be populated by the passive targeting of bubbles circulating through the vasculature.
Regardless, based on our in vitro observations, the amount of increased bubble adhesion due
to ARF substantially outweighs any loss of targeting on the proximal vessel walls. Another
concern is whether acoustically forcing bubbles into vessel walls will cause an increase in
non-specific adhesion and thereby increase the rate of false-positive diagnoses. In this study,
there was no significant difference in targeting efficiency between the control bubble with
ARF application compared to the control bubble with no ARF (Figure 4). However, we
suggest that this would need to be re-evaluated for different adhesion ligands and tumor
types.
B. Comparison to previous work
Previous in vitro work studying the increase in targeting efficiency of ARF-enhanced studies
relative to passive targeted bubbles adhesion has demonstrated a large dependence on
microbubble concentration. There was approximately 3 times more adhesion in passive
targeting experiments without an appreciable difference in ARF efficiency when the bubble
concentration was increased from 2.5 × 106 to 25 × 106 bubbles/mL (Rychak et al. 2005).
This suggests that a larger difference in microbubble targeting effectiveness will be apparent
if a lower concentration of microbubbles is used, though these studies have yet to be
performed in vivo. Additionally, since the magnitude of radiation force is highest at the
resonant frequency of a microbubble (Dayton et al. 2002), the frequency of our radiation
force pulses could have been a source of reduction in expected targeting effectiveness. We
were pulsing at 7 MHz, which was slightly higher than the resonance frequency of our
bubbles (~6 MHz, as calculated using the method described in (Quaia 2005)). Finally,
secondary radiation force is known to create aggregates of multiple microbubbles after
contacting vessel walls (Dayton et al. 1999; Rychak et al. 2005; Kotopoulis and Postema
2009) (Figure 2B). If these aggregates form lasting bonds with integrin targets, they will
contribute to the image signal intensity differently than a single bubble would. This could
have contributed to the variability observed in our in vivo studies.
In prior in vivo molecular imaging studies implementing ARF, Rychak et al. (2007)
optically observed a >20 fold increase in microbubble adhesion in vivo using intravital
microscopy in both the femoral artery and vein of a mouse model for inflammation,
although this study relied on optically counting microbubbles through invasive intravital
microscopy to quantify retention rather than using ultrasound imaging. Thus, a direct
correlation between Rychak’s data and the data presented herein is not possible. Gessner et
al. (2009) previously demonstrated the administration of ARF and acoustic detection of the
targeted bubbles using a prototype high-resolution probe and custom pulse sequences, with
an average microbubble targeting improvement of 13 dB across all image slices when ARF
was used compared to passive targeting. There were many differences between that study
and this one, including the ARF parameters, and the imaging techniques’ contrast
sensitivities, which could account for the differences between the reported increase in
sensitivity facilitated by radiation force in that paper (13 dB ≈ 4.5 fold increase in detected
contrast signal) relative to data presented here.
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C. Limitations and future directions
It was beyond the scope of the in vitro study of observations of contrast agents interacting
with the tube wall to quantify the motion and trajectories of the bubbles after contacting the
tube wall. This was because the aggregates of multiple contrast agents continually formed
clusters of bubbles in an erratic fashion due to secondary radiation forces, and thus made
tracking individual contrast agents very difficult. The lack of this analysis notwithstanding,
the standard deviation projections seen in Figure 2B demonstrate this effect and suggested
that higher pressures would reduce the likelihood of lasting ligand-integrin bond formations.
A more thorough analysis of this lateral motion would help define Po more accurately than
our coarse ability to adjust the amplitude of the ARF pulses permitted.
As mentioned previously, the best strategy for improving targeting is one that maximizes the
probability of microbubble adhesion throughout the tumor. Due to attenuation effects, it was
not possible in our in vivo studies to apply ARF uniformly at all axial depths. One potential
strategy to apply a more homogeneous ARF profile to multiple depths within tissue (not
examined in these studies) would be to sweep through multiple pressures at each spatial
location. If at first a high pressure is used, it facilitates microbubble targeting deeper into
tissue (due to attenuation) while simultaneously over-pushing at shallow depths. If the
pressure is steadily reduced, microbubbles at shallower depths will be pushed at a more
appropriate pressure without negatively affecting the targeted bubbles deeper in the tissue,
since the pressure at these depths will have been reduced and thus the secondary radiation
force effects minimized. Of note, over-pushing targeted contrast agents would likely only be
detrimental to molecular imaging studies in which the lasting integrity of the microbubble’s
bond is critical. This limitation would probably not be a concern in ARF-mediated drug
delivery, where the ultimate goal is rapid and efficient localization and release of a
microbubble’s payload. In many ultrasound-mediated therapies, the microbubbles are
disrupted immediately after pushing towards the endothelium, and long-term adhesion is not
required (Shortencarier et el. 2004; Lum et al. 2006; Kheirolomoom et al. 2007).
The time window over which radiation force is applied may also affect the increase in
microbubble adhesion; if radiation force is administered continuously over several minutes
as microbubbles circulate through the animal, more bubbles will be pushed against the
endothelium, though this increased microbubble traffic at the vessel wall could be
counterproductive if it causes previously adherent agents to become dislodged.
The experiments performed in this manuscript were done on a widely used clinical scanner
without any additional customization of the software or pulse sequences, although we
suggest that improved results would be obtained if dedicated optimized pulse sequencing
and beam focusing/defocusing were available. Our approach did rely on mechnanical
scanning of the transducer to uniformly apply ARF pulses from the 1D linear array across
the volume of tumor tissue, though this would be unnecessary if a 2D matrix array probe
were available for high-resolution contrast imaging.
Conclusion
The studies presented herein provide validation of acoustic radiation force applied with a
clinical ultrasound system as a mechanism to enhance molecular imaging. In all in vivo
studies, the average targeted microbubble signal throughout the 3D tumor volume was
greater when using ARF (at 13 kPa) when compared with passive targeting studies. Our 3D
imaging results demonstrate an improvement in signal intensity of 77.8% to our molecular
target over conventional passive molecular imaging without an increase in non-specific
targeting. Furthermore, experiments suggest that for volumetric administration of radiation
force, there exists an optimal pressure for ARF-enhanced targeting, which is a compromise
Gessner et al. Page 10













between efficient bubble translation and adhesion-disruptive secondary radiation force and
lateral translation effects.
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Experimental diagrams for the in vitro characterization of the effects of radiation force on
microbubbles. A: System used to determine the relationship between microbubble
translational velocity and output pressure from the transducer. B: System used to examine
the effects of secondary radiation force on contrast agents after making contact with the tube
wall. In panel A, the optical axis is along the x direction, the acoustic axis is along the z
direction and the microbubble flow axis is along the y direction. Similarly, in panel B, the
optical axis and the acoustic axis are along the z direction and the microbubble flow axis is
along the y direction.
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Results from optical observations of in vitro radiation force on microbubbles. A: The
translational velocity of contrast agents as a function of radiation force pressure amplitude.
B: Images of standard deviation projections of microbubble lateral translation along the tube
wall during radiation force pulsing at high (19 kPa) and low (8 kPa) pressures. As the
pressure is increased, lateral motion along the wall caused by secondary radiation force can
be clearly visualized as non-spherical trails. Note: the displayed images are negatives of the
actual projections - large values appear dark in these images.
Gessner et al. Page 14














A: The CEF plotted as a function of initial ARF push pressure and tumor diameter.
Minimizing the CEF at a given tumor diameter provides the basis for estimating the optimal
push protocol for an in vivo study (white dashed line). The X’s illustrate the three output
settings that were tested and compared in the in vivo validation studies. B: Simulations
predicting the distance a microbubble would be pushed by ARF pulses for the three different
initial pressure amplitudes as a function of depth into tissue.
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A: A box and whiskers plot displaying the distribution of all mean intensities within
baseline-subtracted targeted bubble images collected in this study. Data is normalized to the
mean pixel intensity within the 0 kPa/cRGD+ dataset collected in each study. Asterisks
indicate a statistically significant increase in targeting (p<0.05) over: * - the RF-0/cRGD+
data, ** - the RF-0/cRGD− data. B: A comparison of the histograms of pixel intensities for
all image slices used in studies using control and targeted microbubbles with and without
radiation force at 13 kPa. These histograms are area-normalized (not intensity normalized),
and show a larger proportion of bright pixel values when targeted bubbles are used, and
even more when radiation force is used with targeted bubbles.
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A side-by-side comparison of two 3D conically-stratified hinged cutaway images. B-mode
images (grayscale) are registered to the corresponding CPS images acquired 10 minutes
after contrast injection (green). In both of these images, the same dose of targeted
microbubbles was administered to the same animal. Radiation force was not applied in
image A, and was applied at 13 kPa in image B. The imaging field of view was 1.2 cm × 1.1
cm × 1.2 cm.
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